CNA Finance |
Is Eteplirsen About To Be Approved?
Seeking Alpha Decision to delay suggests that the FDA may be looking for a way to approve Eteplirsen. This delay is likely to push back the approval timeline by several months. Eteplirsen could be the first drug approved for use in DMD patients. The FDA once again ... Sarepta soars after the FDA blinks (again) on Duchenne drug decision Sarepta Therapeutics Announces FDA Request For Dystrophin Data Prior To Making A Decision on Eteplirsen NDA Trade-Ideas: Sarepta Therapeutics (SRPT) Is Today's Post-Market Leader Stock |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGfhTL9ASpGom_TnWCUodPAe-xA8g&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779127891613&ei=aJ5WV8ztJ8HbpweXlaeoCw&url=http://seekingalpha.com/article/3980337-eteplirsen-approved
via IFTTT
No comments:
Post a Comment